242 related articles for article (PubMed ID: 38587427)
1. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
[TBL] [Abstract][Full Text] [Related]
2. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
[TBL] [Abstract][Full Text] [Related]
3. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
Liu YM; Shahed-Al-Mahmud M; Chen X; Chen TH; Liao KS; Lo JM; Wu YM; Ho MC; Wu CY; Wong CH; Jan JT; Ma C
Cell Rep; 2020 Aug; 32(6):108016. PubMed ID: 32755598
[TBL] [Abstract][Full Text] [Related]
4. Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.
Cheemarla NR; Watkins TA; Mihaylova VT; Foxman EF
J Infect Dis; 2024 May; 229(5):1430-1434. PubMed ID: 37722683
[TBL] [Abstract][Full Text] [Related]
5. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
Du X; Zuo X; Meng F; Han C; Ouyang W; Han Y; Gu Y; Zhao X; Xu F; Qin FX
Cell Prolif; 2021 Jan; 54(1):e12953. PubMed ID: 33211371
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
O'Keefe BR; Giomarelli B; Barnard DL; Shenoy SR; Chan PK; McMahon JB; Palmer KE; Barnett BW; Meyerholz DK; Wohlford-Lenane CL; McCray PB
J Virol; 2010 Mar; 84(5):2511-21. PubMed ID: 20032190
[TBL] [Abstract][Full Text] [Related]
7. Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.
Ishag HZ; Li C; Huang L; Sun MX; Wang F; Ni B; Malik T; Chen PY; Mao X
Arch Virol; 2013 Feb; 158(2):349-58. PubMed ID: 23053519
[TBL] [Abstract][Full Text] [Related]
8. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
[TBL] [Abstract][Full Text] [Related]
9. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
[TBL] [Abstract][Full Text] [Related]
10. Porcine deltacoronavirus infection is inhibited by Griffithsin in cell culture.
Tang R; Guo L; Fan Q; Zhang L; Wang Y; Zhang X; Shi D; Wu Y; Shi H; Liu J; Chen J; Feng L
Vet Microbiol; 2022 Jan; 264():109299. PubMed ID: 34896854
[TBL] [Abstract][Full Text] [Related]
11. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
12. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
[TBL] [Abstract][Full Text] [Related]
14. A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life.
Duan Q; Xia S; Jiao F; Wang Q; Wang R; Lu L; Jiang S; Xu W
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458385
[TBL] [Abstract][Full Text] [Related]
15. Influenza A virus entry inhibitors targeting the hemagglutinin.
Yang J; Li M; Shen X; Liu S
Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380
[TBL] [Abstract][Full Text] [Related]
16. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle.
Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391
[TBL] [Abstract][Full Text] [Related]
18. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity.
Bai L; Zhao Y; Dong J; Liang S; Guo M; Liu X; Wang X; Huang Z; Sun X; Zhang Z; Dong L; Liu Q; Zheng Y; Niu D; Xiang M; Song K; Ye J; Zheng W; Tang Z; Tang M; Zhou Y; Shen C; Dai M; Zhou L; Chen Y; Yan H; Lan K; Xu K
Cell Res; 2021 Apr; 31(4):395-403. PubMed ID: 33603116
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening.
Weisshaar M; Cox R; Morehouse Z; Kyasa SK; Yan D; Oberacker P; Mao S; Golden JE; Lowen AC; Natchus MG; Plemper RK
J Virol; 2016 Aug; 90(16):7368-7387. PubMed ID: 27252534
[TBL] [Abstract][Full Text] [Related]
20. Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
Chen Y; Wu Y; Chen S; Zhan Q; Wu D; Yang C; He X; Qiu M; Zhang N; Li Z; Guo Y; Wen M; Lu L; Ma C; Guo J; Xu W; Li X; Li L; Jiang S; Pan X; Liu S; Tan S
J Virol; 2022 Dec; 96(24):e0124522. PubMed ID: 36468859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
